Alira Health

We Announce our Role as Advisor to Sagard NewGen

News
Category:
Published on:
September 11, 2020

Alira Health is pleased to announce its role as Advisor to Sagard NewGen for the equity investment in Laboratoires Delbert. This recent capital raise of €40m supports the company’s growth strategy and mission of keeping essential medicinal products on the market and available to patients around the world.

For more information, please contact Benjamin Chambon.

 

For more information about Alira Health’s Transaction Advisory practice

Click here

Related news

Events October 6, 2022
The MedTech Conference 2022
We are pleased to share that we will be joining the MedTech Conference 2022 as sponsors and speakers! This year’s edition will have more than 100 sessions focusing on today’s hot topics.
M&A MedTech Regulatory
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. The financing was provided by key existing investors Creadev, an evergreen(...)
M&A MedTech Pharma Press Release
Articles August 3, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
Key questions to ask to help ensure that your next transaction advisory firm partnership is best positioned to achieve your goals.
M&A
News April 12, 2021
Alira Health Strengthens Growth Strategy with $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
M&A MedTech Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
M&A Pharma
News November 29, 2020
Alira Health as Strategic Advisor to Benvic in Acquisition Luc & Bel
We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.
CDMO M&A
Reports October 10, 2020
MedDevice Contract Development and Manufacturing M&A Report
How do Medical Device OEMs make supply chain decisions and how do market and competitive dynamics influence the outsourcing industry?
M&A MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.